サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1556595

慢性副鼻腔炎市場レポート：2030年までの動向、予測、競合分析

Chronic Rhinosinusitis Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

慢性副鼻腔炎市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年08月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

慢性副鼻腔炎の動向と予測

世界の慢性副鼻腔炎市場は、2024年から2030年にかけてCAGR 7.5％で成長すると予測されます。この市場の主な促進要因は、臨床試験数の増加、革新的な治療アプローチへのニーズの高まり、診断ツールの継続的な技術進歩です。世界の慢性副鼻腔炎市場の将来は、病院、専門クリニック、外来手術センター市場での機会により有望視されています。

セグメント別慢性副鼻腔炎

本調査では、世界の慢性副鼻腔炎の治療タイプ別、疾患表現型別、最終用途別、地域別の予測を掲載しています。

慢性副鼻腔炎市場の洞察

Lucintelは、ステロイド点鼻薬が予測期間中に最も高い成長を遂げると予測しています。

この市場の中では、病院が予測期間中に最も高い成長を示すと予想されます。

北米は予測期間中に最も高い成長が見込まれます。

よくある質問

Q1.市場の成長予測は：

A1.世界の慢性副鼻腔炎市場は、2024年から2030年にかけてCAGR 7.5％で成長すると予測されています。

Q2.市場の成長に影響を与える主な促進要因は：

A2.慢性副鼻腔炎市場の主な促進要因は、臨床試験数の増加、革新的な治療アプローチに対するニーズの高まり、診断ツールの継続的な技術進歩です。

Q3.市場の主要セグメントは：

A3.慢性副鼻腔炎市場の将来は、病院、専門クリニック、外来手術センター市場での機会により有望視されています。

Q4.市場の主要企業は：

A4.慢性副鼻腔炎の主要企業の一部は以下の通りです：

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew

Q5.今後、最大となる市場セグメントは：

A5.Lucintelは、ステロイド点鼻薬が予測期間中に最も高い成長を遂げると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は：

A6.予測期間中、北米が最も高い成長が見込まれます。

Q7.レポートのカスタマイズは可能か：

A7.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の慢性副鼻腔炎市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 慢性副鼻腔炎の世界市場動向（2018～2023年）と予測（2024～2030年）
  • 治療タイプ別慢性副鼻腔炎の世界市場
    • 医療機器
    • 薬物
    • 点鼻薬
    • ステロイド点鼻薬
    • 手術
    • その他
  • 疾患表現型別慢性副鼻腔炎の世界市場
    • 非好酸球性慢性副鼻腔炎
    • 好酸球性慢性副鼻腔炎
    • 感染性慢性副鼻腔炎
    • アレルギー性真菌性副鼻腔炎
    • その他
  • 慢性副鼻腔炎の最終用途別市場規模
    • 病院
    • 専門クリニック
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

  • 地域別慢性副鼻腔炎の世界市場
  • 北米の慢性副鼻腔炎市場
  • 欧州の慢性副鼻腔炎市場
  • アジア太平洋地域の慢性副鼻腔炎市場
  • その他地域慢性副鼻腔炎市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 治療タイプ別の世界の慢性副鼻腔炎市場の成長機会
    • 疾患表現型別の世界の慢性副鼻腔炎市場の成長機会
    • 慢性副鼻腔炎の世界市場における最終用途別の成長機会
    • 地域別の世界の慢性副鼻腔炎市場の成長機会
  • 世界の慢性副鼻腔炎市場の新たな動向
  • 戦略分析
    • 新製品開発
    • 世界の慢性副鼻腔炎市場の能力拡大
    • 慢性副鼻腔炎の世界市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 主要企業の企業プロファイル

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew
目次

Chronic Rhinosinusitis Trends and Forecast

The future of the global chronic rhinosinusitis market looks promising with opportunities in the hospital, specialty clinic, and ambulatory surgical center markets. The global chronic rhinosinusitis market is expected to grow with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing number of clinical trials, rise in the need for innovative therapeutic approaches, and ongoing technological advancements in diagnostic tools.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Chronic Rhinosinusitis by Segment

The study includes a forecast for the global chronic rhinosinusitis by treatment type, disease phenotype, end use, and region.

Chronic Rhinosinusitis Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Medical Devices
  • Drugs
  • Nasal Drops
  • Steroid Nasal Sprays
  • Surgery
  • Others

Chronic Rhinosinusitis Market by Disease Phenotype [Shipment Analysis by Value from 2018 to 2030]:

  • Non-Eosinophilic Chronic Rhinosinusitis
  • Eosinophilic Chronic Rhinosinusitis
  • Infectious Chronic Rhinosinusitis
  • Allergic Fungal Rhinosinusitis
  • Others

Chronic Rhinosinusitis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Chronic Rhinosinusitis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Chronic Rhinosinusitis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chronic rhinosinusitis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chronic rhinosinusitis companies profiled in this report include-

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew

Chronic Rhinosinusitis Market Insights

Lucintel forecasts that steroid nasal spray is expected to witness the highest growth over the forecast period.

Within this market, hospital is expected to witness the highest growth over the forecast period.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Chronic Rhinosinusitis Market

Market Size Estimates: Chronic rhinosinusitis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chronic rhinosinusitis market size by treatment type, disease phenotype, end use, and region in terms of value ($B).

Regional Analysis: Chronic rhinosinusitis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment types, disease phenotypes, end uses, and regions for the chronic rhinosinusitis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chronic rhinosinusitis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for chronic rhinosinusitis market?

Answer: The global chronic rhinosinusitis market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the chronic rhinosinusitis market?

Answer: The major drivers for this market are growing number of clinical trials, rise in the need for innovative therapeutic approaches, and ongoing technological advancements in diagnostic tools.

Q3. What are the major segments for chronic rhinosinusitis market?

Answer: The future of the chronic rhinosinusitis market looks promising with opportunities in the hospital, specialty clinic, and ambulatory surgical center markets.

Q4. Who are the key chronic rhinosinusitis market companies?

Answer: Some of the key chronic rhinosinusitis companies are as follows:

  • Lyra Therapeutics
  • Novartis
  • Medtronic
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Dr. Reddy's Laboratories
  • Stryker Corporation
  • Bayer
  • Smith & Nephew

Q5. Which chronic rhinosinusitis market segment will be the largest in future?

Answer: Lucintel forecasts that steroid nasal spray is expected to witness the highest growth over the forecast period.

Q6. In chronic rhinosinusitis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the chronic rhinosinusitis market by treatment type (medical devices, drugs, nasal drops, steroid nasal sprays, surgery, and others), disease phenotype (non-eosinophilic chronic rhinosinusitis, eosinophilic chronic rhinosinusitis, infectious chronic rhinosinusitis, allergic fungal rhinosinusitis, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chronic Rhinosinusitis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Chronic Rhinosinusitis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Chronic Rhinosinusitis Market by Treatment Type
    • 3.3.1: Medical Devices
    • 3.3.2: Drugs
    • 3.3.3: Nasal Drops
    • 3.3.4: Steroid Nasal Sprays
    • 3.3.5: Surgery
    • 3.3.6: Others
  • 3.4: Global Chronic Rhinosinusitis Market by Disease Phenotype
    • 3.4.1: Non-Eosinophilic Chronic Rhinosinusitis
    • 3.4.2: Eosinophilic Chronic Rhinosinusitis
    • 3.4.3: Infectious Chronic Rhinosinusitis
    • 3.4.4: Allergic Fungal Rhinosinusitis
    • 3.4.5: Others
  • 3.5: Global Chronic Rhinosinusitis Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Chronic Rhinosinusitis Market by Region
  • 4.2: North American Chronic Rhinosinusitis Market
    • 4.2.1: North American Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.2.2: North American Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Chronic Rhinosinusitis Market
    • 4.3.1: European Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.3.2: European Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Chronic Rhinosinusitis Market
    • 4.4.1: APAC Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.4.2: APAC Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Chronic Rhinosinusitis Market
    • 4.5.1: ROW Chronic Rhinosinusitis Market by Treatment Type: Medical Devices, Drugs, Nasal Drops, Steroid Nasal Sprays, Surgery, and Others
    • 4.5.2: ROW Chronic Rhinosinusitis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Chronic Rhinosinusitis Market by Treatment Type
    • 6.1.2: Growth Opportunities for the Global Chronic Rhinosinusitis Market by Disease Phenotype
    • 6.1.3: Growth Opportunities for the Global Chronic Rhinosinusitis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Chronic Rhinosinusitis Market by Region
  • 6.2: Emerging Trends in the Global Chronic Rhinosinusitis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Chronic Rhinosinusitis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chronic Rhinosinusitis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lyra Therapeutics
  • 7.2: Novartis
  • 7.3: Medtronic
  • 7.4: GlaxoSmithKline
  • 7.5: AstraZeneca
  • 7.6: Sanofi
  • 7.7: Dr. Reddy's Laboratories
  • 7.8: Stryker Corporation
  • 7.9: Bayer
  • 7.10: Smith & Nephew